Literature DB >> 27567724

Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].

Saul Martinez-Horta1, Jesus Perez-Perez2, Erik van Duijn3, Ramon Fernandez-Bobadilla1, Mar Carceller4, Javier Pagonabarraga2, Berta Pascual-Sedano2, Antonia Campolongo2, Jesus Ruiz-Idiago5, Frederic Sampedro6, G Bernhard Landwehrmeyer7, Jaime Kulisevsky8.   

Abstract

Entities:  

Year:  2016        PMID: 27567724     DOI: 10.1016/j.parkreldis.2016.08.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  2 in total

1.  Metformin intake associates with better cognitive function in patients with Huntington's disease.

Authors:  David Hervás; Victoria Fornés-Ferrer; Ana Pilar Gómez-Escribano; María Dolores Sequedo; Carmen Peiró; José María Millán; Rafael P Vázquez-Manrique
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

2.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.